USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: COMPENDIA BIOSCIENCE, INC.
City: ANN ARBOR
State: MI
Zip+4: 48104-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,655,689.00 3
SBIR Phase II $3,423,270.00 2

Award List:

Development of Oncomine Professional as a Platform for Biopharmaceutical Research

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel R. Rhodes
Award Amount: $179,109.00
Abstract:
DESCRIPTION (provided by applicant): DNA microarray studies, largely sponsored by the NIH and other granting agencies, have generated a wealth of data uncovering the complex gene expression patterns of cancer. Currently however, there is no unifying organ izational or bioinformatics resource to… More

Development of Oncomine Professional as a Platform for Biopharmaceutical Research

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator: Daniel R. Rhodes
Award Amount: $2,248,644.00
Abstract:
DESCRIPTION (provided by applicant): DNA microarray studies, largely sponsored by the NIH and other granting agencies, have generated a wealth of data uncovering the complex gene expression patterns of cancer. Currently however, there is no unifying organ izational or bioinformatics resource to… More

Biodata Management of Genomics Data from Cancer Cell Lines and Tumors

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel R. Rhodes
Award Amount: $151,358.00
Abstract:
DESCRIPTION (provided by applicant): It is now clear that response to targeted therapies in cancer is dictated by the molecular characteristics of an individual patient's tumor. The industry is increasingly looking to genomics-based analyses to link drug r esponse phenotypes to underlying genetic… More

Incorporating microRNA data and analyses into the leading cancer genomics portal

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel R. Rhodes
Award Amount: $1,325,222.00
Abstract:
DESCRIPTION (provided by applicant): Micro-RNAs (miRNAs) are small non-coding RNAs that control gene expression by regulating messenger (mRNA) translation. miRNAs can act as oncogenes or tumor suppressors, and the differential expression of miRNAs has been correlated with cancer diagnosis, staging,… More

Incorporating microRNA data and analyses into the leading cancer genomics portal

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Daniel R. Rhodes – 734-904-0365
Award Amount: $1,174,626.00
Abstract:
DESCRIPTION (provided by applicant): Micro-RNAs (miRNAs) are small non-coding RNAs that control gene expression by regulating messenger (mRNA) translation. miRNAs can act as oncogenes or tumor suppressors, and the differential expression of miRNAs has beencorrelated with cancer diagnosis, staging,… More